T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
about
The Role of Imaging in Aortic Valve DiseaseRecent advances in cardiac magnetic resonance.Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis.Synthetic hematocrit derived from the longitudinal relaxation of blood can lead to clinically significant errors in measurement of extracellular volume fraction in pediatric and young adult patientsPersonalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Non-invasive imaging in cardiology for the generalist.Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions.Mini-Review on Cardiac Metabolic Imaging: current imaging modalities and future perspectives.Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care.Correlation between right ventricular T1 mapping and right ventricular dysfunction in non-ischemic cardiomyopathy.Effects of short-term levothyroxine therapy on myocardial injuries in patients with severe overt hypothyroidism: Evidence from a cardiac MRI Study.Myocardial Architecture, Mechanics, and Fibrosis in Congenital Heart Disease.Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for CardiovascularAdvanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis.Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction.Native T1 reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: A systematic review and meta-analysis.Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time?ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.Substrate-dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patients.The relationship between cardiovascular magnetic resonance imaging measurement of extracellular volume fraction and clinical outcomes in adults with repaired tetralogy of Fallot.Increased myocardial native T1 relaxation time in patients with nonischemic dilated cardiomyopathy with complex ventricular arrhythmia.Native T1 value in the remote myocardium is independently associated with left ventricular dysfunction in patients with prior myocardial infarction.Variability of cardiovascular magnetic resonance (CMR) T1 mapping parameters in healthy volunteers during long-term follow-up.Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.Potential for Rapid and Cost-Effective Cardiac Magnetic Resonance in the Developing (and Developed) World
P2860
Q26744817-63A83487-CDC5-4CFE-AC80-1444198A0782Q28066746-BE7F475C-1A4D-4326-BBEB-71C55C57A529Q33727302-2197CA1D-5AF8-44BD-8D7B-3EFD639CCD7BQ37726262-7A45719F-41D5-4C2F-BC39-0C7C0EC41E9CQ38646236-E820E63D-34A9-46FD-B602-8F028DF34AD6Q38659406-4E831891-EEF9-4253-BD40-3D382175E35AQ38660293-E899042A-B34D-4569-8459-38E6A6D8305AQ38671622-33C92C10-83AA-47E0-9A82-4E7C976F5006Q38687598-BC8F149A-2DE2-42FB-8AAA-278A919B392FQ38830086-8FB2F4BA-0A80-4DE5-B103-A938BE7F9610Q38867726-F7678C44-F33C-4802-AFCD-976890C9C8D8Q38890676-CFCEFBB6-9434-4D49-937A-0DEA7D6E97A0Q39355931-5E61BA1E-1FA4-4920-9C9B-728940BB14E5Q42365793-87CCAC33-8917-4BDB-9D30-ECD79AAC5BB5Q42373017-FB074689-C5AE-4726-A1CA-4ECD962516B3Q42374261-16EB76C9-871D-4EB2-BC7E-47ADD011227CQ45069359-126ABFCF-9EB7-4BC1-99E0-B5E51CD0FEEAQ47297387-17178B34-7D98-41E3-8601-123FA0D4E950Q47608249-3A8DC2A8-C7C7-433C-A312-E56D20279386Q47619369-F2CE10A2-008F-4AD0-87B3-E63876641AC8Q47801890-DC5D9D55-399E-482F-9941-CE31FA739BB3Q48016282-414572D3-3782-4972-B741-0D112955ECC4Q48171316-019DBD7E-405E-4677-9EF1-581C02C7DE44Q50089609-B520B462-BA53-4B13-BB14-AFAFCB1523CAQ50521920-3812AD59-CF27-4066-8599-7B1C29A75EAAQ50916534-553607FB-5B74-48B4-B1E7-46CE3B85A6F2Q52807794-80124081-616C-4593-B816-CAD3DEF1F80FQ52877004-84F163BB-3BE8-4D94-8C39-261A136FDB0EQ58127446-CF81C498-03FC-472C-A119-34C31264CDC4
P2860
T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
T1-Mapping and Outcome in Noni ...... e Mortality and Heart Failure.
@en
type
label
T1-Mapping and Outcome in Noni ...... e Mortality and Heart Failure.
@en
prefLabel
T1-Mapping and Outcome in Noni ...... e Mortality and Heart Failure.
@en
P2093
P1476
T1-Mapping and Outcome in Noni ...... e Mortality and Heart Failure.
@en
P2093
Adelina Doltra
Andrew Jabbour
Ben Goodman
Chung-Yao Yu
Darius Dabir
Eduardo Arroyo Ucar
Eva Herrmann
Gerry Carr-White
Gonca Suna
International T1 Multicentre CMR Outcome Study
P356
10.1016/J.JCMG.2015.12.001
P577
2016-01-01T00:00:00Z